Nikolaus R. McFarland, Ph.D.

1988-1992 University of Chicago, Chicago, IL 
 1992-2002 University of Rochester, Rochester, NY 
 2002-2006 Neurology University of Virginia School of Medicine, Charlottesville, VA, United States 
 2006-2010 Neurology Massachusetts General Hospital & Harvard Medical School, Boston, MA, United States 
 2010- Neurology University of Florida College of Medicine 
Parkinsonism, atypical parkinson disorders, neurodegenerative models, AAV
"Nikolaus McFarland"
Mean distance: 15.59 (cluster 17)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mir MJ, Herndon NE, Wagle Shukla A, et al. (2024) The Vocal Flutter of Multiple System Atrophy: A Parkinsonian-Type Phenomenon? Movement Disorders Clinical Practice
Wilkes BJ, Tobin ER, Arpin DJ, et al. (2023) Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson's disease and atypical parkinsonism. Npj Parkinson's Disease. 9: 85
Patterson CG, Joslin E, Gil AB, et al. (2022) Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial. Trials. 23: 855
Mitchell T, Wilkes BJ, Archer DB, et al. (2022) Advanced diffusion imaging to track progression in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neuroimage. Clinical. 34: 103022
Quattrone A, Bianco MG, Antonini A, et al. (2022) Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society
Arpin DJ, Mitchell T, Archer DB, et al. (2021) Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo-Controlled Trial of Rasagiline. Movement Disorders : Official Journal of the Movement Disorder Society
Hass EW, Sorrentino ZA, Lloyd GM, et al. (2021) Robust α-synuclein pathology in select brainstem neuronal populations is a potential instigator of multiple system atrophy. Acta Neuropathologica Communications. 9: 80
Tanner CM, Cummings SR, Schwarzschild MA, et al. (2021) The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. Npj Parkinson's Disease. 7: 16
Quattrone A, Antonini A, Vaillancourt DE, et al. (2020) A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study. Movement Disorders : Official Journal of the Movement Disorder Society
Burns MR, McFarland NR. (2020) Current Management and Emerging Therapies in Multiple System Atrophy. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics
See more...